| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.13 | 0.05 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.05 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.06 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |